Impact of minimum enrollment period requirements on disease prevalence estimates derived from claims data

被引:0
|
作者
Murdock, Dana J. [1 ]
Jalbert, Jessica J. [2 ]
Ge, Wenzhen [1 ]
Sanchez, Robert [1 ]
Wu, Ning [2 ]
机构
[1] Regeneron Pharmaceut, Tarrytown, NY USA
[2] Regeneron Pharmaceut Inc, Tarrytown, NY USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
528
引用
收藏
页码:246 / 246
页数:1
相关论文
共 50 条
  • [1] Enrollment factors and bias of disease prevalence estimates in administrative claims data
    Jensen, Elizabeth T.
    Cook, Suzanne F.
    Allen, Jeffery K.
    Logie, John
    Brookhart, Maurice Alan
    Kappelman, Michael D.
    Dellon, Evan S.
    ANNALS OF EPIDEMIOLOGY, 2015, 25 (07) : 519 - 525
  • [2] Impact of increasing enrollment requirements in administrative claims data
    Gibbs, Liza R.
    Estevez, Irisdaly
    Gilpin, Katherine K.
    Garry, Elizabeth M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 246 - 247
  • [3] Impact of extending the lookback period on the estimated prevalence of inflammatory bowel disease in administrative claims data
    Dawwas, Ghadeer K.
    Haynes, Kevin
    Parlett, Lauren
    Brensinger, Colleen M.
    Chen, Xiaoxue
    Wu, Qufei
    Kappelman, Michael D.
    Lewis, James D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 414 - 415
  • [4] Impact of Eligibility Length on Prevalence Estimates Using Automated Healthcare Claims Data
    Zhu, Yanmin
    Liu, Wei
    Li, Yan
    Winterstein, Almut G.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 583 - 583
  • [5] Prevalence of Corneal Dystrophies in the United States: Estimates from Claims Data
    Moller, Hans Ulrik
    Sunde, Lone
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (01) : 387 - 387
  • [6] Prevalence of Corneal Dystrophies in the United States: Estimates from Claims Data
    Musch, David C.
    Niziol, Leslie M.
    Stein, Joshua D.
    Kamyar, Roheena M.
    Sugar, Alan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (09) : 6959 - 6963
  • [7] Comparing prevalence estimates from US claims data by two methods
    Zito, Julie M.
    Korelitz, James J.
    Valluri, Satish
    Gardner, James F.
    Bethel, James
    Mattison, Donald R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S120 - S120
  • [8] Author Response: Prevalence of Corneal Dystrophies in the United States: Estimates from Claims Data
    Musch, David C.
    Niziol, Leslie M.
    Stein, Joshua D.
    Kamyar, Roheena M.
    Sugar, Alan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (01) : 388 - 388
  • [9] Robustness of prevalence estimates derived from misclassified data from administrative databases
    Ladouceur, Martin
    Rahme, Elham
    Pineau, Christian A.
    Joseph, Lawrence
    BIOMETRICS, 2007, 63 (01) : 272 - 279
  • [10] Comparison of Census Tract-Level Chronic Disease Prevalence Estimates From 500 Cities and Local Health Claims Data
    Monaghan, Alyssa
    Jones, Lynda
    Brink, LuAnn
    Hacker, Karen
    JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, 2022, 28 (01): : E92 - E95